Miss the Aug. 18 AOBD resident webinar? View the recording now! (Passcode: 5psJ?Rft)
Longitudinal Assessment References
Due to copyright restrictions, the AOBD cannot provide most reference materials used for longitudinal assessment. However, a list of the references used for the 2025 and 2026 longitudinal assessments can be found below.
Exam references
2026 references
- Aesthetic Surgery Journal (Aug 2024); Vol. 44, Issue 9; Increasing precision when targeting the depressor anguli oris muscle with neuromodulators: an ultrasound-based investigation
- Aesthetic Surgery Journal (May 2021); Vol. 41, Issue 6; Three-dimensional description of the angular artery in the nasolabial fold; pg. 679-704
- Allergologie Select (Jan 2022); Issue 6; Cutaneous mastocytosis in childhood; pg. 1-10
- American Family Physician (Apr 2020); Vol. 101, Issue 7; Cutaneous cryosurgery for common skin conditions; pg. 399-406
- American Family Physician (Mar 2021); Vol. 103, Issue 6; Topical corticosteroids: choice and application; pg. 337-343
- An unusual adverse event of botulinum toxin injection in the lower face; pg. 1381-1384
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2020); pg. 1315-1317, 1341-1355
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2020); pg. 800-802, 4500-4502
- Andrews’ Diseases of the Skin: Clinical Dermatology, 14th ed. (2024); Ch. 32
- Annals of Medicine (Dec 2022); Vol. 54, Issue 1; Optimal diagnosis and management of common nail disorders; pg. 694-712
- Canadian Journal of Health Technologies (2022); Vol. 2, Issue 11
- Centers for Disease Control and Prevention (Updated Mar 2024); About leishmaniasis
- Cleveland Clinic (Updated Sep 2022); Tungiasis
- Clinical Anatomy (Jan 2018); Vol. 31, Issue 1; The facial artery: a comprehensive anatomical review; pg. 99‐10
- Clinics in Plastic Surgery (Oct 2019); Vol. 46, Issue 4; Facial anatomy for filler injection: the superficial musculoaponeurotic system (SMAS) is not just for facelifting; pg. 603‐612
- Dermatologic Surgery (2018); Ch. 14: Superficial Biopsy Techniques
- Dermatologic Surgery (2018); Ch. 14: Superficial Biopsy Techniques;(Nov 2021); Vol. 7, Issue 12; Sensitivity and specificity of anti-double-stranded RNA immunofluorescence for universal detection of viral infection in respiratory specimens; pg. e0847
- Dermatologic Surgery (May 2018); Vol. 44, Issue 5; Use of nitrous oxide in dermatology: a systematic review; pg. 661-669
- Dermatology, 4th ed. (2018)
- Ch. 77; pg. 1358-1360
- Ch. 85; pg. 1529, 1533
- Dermatology, 5th ed. (2024)
- Ch. 137; pg. 2400-2401
- pg. 615-620
- DermNet (Updated 2003); Stretch marks
- DermNet (Updated 2004); Skin tag
- DermNet (Updated Dec 2019) Acrodermatitis enteropathica
- Erythema multiforme associated with the immune checkpoint inhibitors: a disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System; pg. 1233-1234
- Executive summary: consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients; pg. 1271-1275
- Experimental Biology & Medicine (May 2023); Vol. 248, Issue 5; JAK inhibitors for the treatment of VEXAS syndrome; pg. 394-398
- Expert Review of Clinical Immunology (Feb 2023); Vol. 19, Issue 2; An update on VEXAS syndrome; pg. 203-215
- FDA.gov (Updated 2011); Highlights of prescribing information
- Fitzpatrick’s Dermatology, 9th ed. (2019); Ch. 145
- Raynaud Phenomenon
- Global Medical Genetics (Jul 2023); Vol. 10, Issue 3; VEXAS syndrome – review; pg. 133-143
- Harrison’s Principles of Internal Medicine, 21st ed. (2022); Ch. 360: Systemic Sclerosis (Scleroderma) and Related Disorders
- Hurwitz Clinical Pediatric Dermatology, 6th ed.
- Ch. 12; pg. 341-342
- Ch. 12; pg. 347
- Ch. 7; pg. 195
- Ch. 9; pg. 251-254
- Indian Journal of Dermatology (2020); Dermatologic effects of corticosteroids
- International Journal of Hematology (May 2024); VEXAS syndrome; pg. 1-10
- Journal of Allergy and Clinical Immunology (Jan 2022); Vol. 149, Issue 1; Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patient with VEXAS; pg. 432-439
- Journal of Clinical Medicine (Feb 2024); Vol. 13, Issue 4; VEXAS and myelodysplastic syndrome: an interdisciplinary challenge; pg. 1-10
- Journal of Cosmetic Dermatology (Nov 2020); Vol. 20, Issue 5
- Journal of Cutaneous Pathology (Dec 2019); Vol. 46, Issue 12; BRCA1-associated protein (BAP1)-inactivated melanocytic tumors; pg. 965-972
- Journal of the American Academy of Dermatology (Dec 2024); Vol. 91, Issue 6
- Journal of the American Academy of Dermatology (Feb 2022); Vol. 86, Issue 2; The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses part 1: zinc, selenium, copper, vitamin A, and vitamin C; pg. 267-278
- Journal of the American Academy of Dermatology (Jan 2025); Acral lentiginous melanoma. Part II. Staging, surgical management, the role of systemic therapy, shortcomings and future directions
- Journal of the American Academy of Dermatology (Jun 2024); Vol. 90, Issue 6; Mitigation of risk of botulinum toxin A-induced blepharoptosis with hyperconcentrated glabellar injections; pg. 1309-1310
- Journal of the American Academy of Dermatology (May 2016); Vol. 74, Issue 5; Immediate skin responses to laser and light treatments: therapeutic endpoints: how to obtain efficacy; pg. 821-833
- Journal of the American Academy of Dermatology (May 2021); Vol. 84, Issue 5; Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: a multicenter prospective study; pg. 1378-1384
- Journal of the American Academy of Dermatology (Nov 2019); Vol. 81, Issue 5; Skin changes in the obese patient; pg. 1041-1042
- Journal of the American Academy of Dermatology (Oct 2023); Vol. 89, Issue 4; Alpha-gal syndrome: a review for the dermatologist; pg. 750-757
- Journal of the American Academy of Dermatology (Oct 2024); Lentigo maligna part II: management
- Journal of the American Academy of Dermatology (Sep 2024); Vol. 91, Issue 3; Extramammary Paget disease. Part I. Epidemiology, pathogenesis, clinical features and diagnosis; pg. 409-418
- Nature Communications (Jan 2024); Vol. 15, Number 910; VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation; pg. 1-17
- Pathology (Mar 2023); Vol. 55, Issue 2; An update on genomic aberrations in Spitz naevi and tumours; pg. 196-205
- Pathology Outlines (Updated Dec 2024); Skin nontumor
- Rheumatology (Nov 2023); Vol. 62, Issue 11; How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies; pg. 3518-3525
- StatPearls (Updated Oct 2023); Selenium deficiency
- The American Journal of Surgical Pathology (May 2024); Vol. 48, Issue 5; BRAF mutated and morphologically Spitzoid tumors, a subgroup of melanocytic neoplasms difficult to distinguish from true Spitz neoplasms; pg. 538-545
- The British Journal of Dermatology (Mar 2022); Vol. 186, Issue 3; Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients; pg. 564-574
- The Journal of Allergy and Clinical Immunology (May 2023); Vol. 151, Issue 5; Autoimmune manifestations in VEXAS: opportunities for integration and pitfalls to interpretation; pg. 1204-1214
- Journal of the American Academy of Dermatology (May 2016); Vol. 74, Issue 5; The most common cutaneous drug reactions and culprit medications encountered on the dermatology consult service: a 5-year experience at a tertiary academic center
- Treatment options for VEXAS syndrome; pg. 1-36; World Journal of Otorhinolaryngology – Head and Neck Surgery (Aug 2023); Vol. 9, Issue 3; Facial fillers: relevant anatomy, injection techniques, and complications; pg. 227-235
2025 references
- Allergy (May 2015); Vol. 69, Issue 5; Classification, diagnosis, and approach to treatment for angioedema: Consensus report from the Hereditary Angioedema International Working Group; pg. 602-616
- American Osteopathic College of Dermatology (Updated 2024); Nevoid basal cell carcinoma syndrome. https://www.aocd.org/page/NevoidBCC
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); Ch. 12; pg. 153-168
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); pg. 2435-2951
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); pg. 2795-2804
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); pg. 3007-3020
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); pg. 3466-3472
- Andrews’ Diseases of the Skin: Clinical Dermatology, 13th ed. (2019); Ch. 11
- Annals of the Rheumatic Diseases (Apr 2019); Vol. 78, Issue 4; Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: A retrospective analysis of pooled data from 21 clinical trials; pg. 473-479
- Contact Dermatitis (May 2022); Vol. 87, Issue 5; Contact dermatitis in children caused by diabetes devices; pg. 406-413. https://onlinelibrary.wiley.com/doi/full/10.1111/cod.14166
- Current Rheumatology Reports (Jan 2013); Vol. 15, Issue 1; Management of Raynaud’s phenomenon and digital ischemia; pg. 303-310
- Cutis (Jun 2020); Vol. 105, Issue 6; Isobornyl acrylate and diabetic devices steal the show for the 2020 American Contact Dermatitis Society Allergen of the Year; pg. 283-285. https://pubmed.ncbi.nlm.nih.gov/32716991/
- Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery (May 2018); Vol. 44, Issue 5; Use of nitrous oxide in dermatology: A systematic review; pg. 661-669
- Dermatology, 4th ed. (2017); Pregnancy Dermatoses; pg. 472-483
- DermNet (Updated Aug 2019); Benzalkonium chloride contact dermatitis. https://dermnetnz.org/topics/benzalkonium-chloride-contact-dermatitis
- DermNet (Updated Sep 2021); Pemphigoid gestationis. https://dermnetnz.org/topics/pemphigoid-gestationis
- DermNet (Updated Feb 2023); Dyshidrotic eczema (pompholyx). https://dermnetnz.org/topics/dyshidrotic-eczema
- DermNet (Updated Apr 2023); Formaldehyde allergy. https://dermnetnz.org/topics/formaldehyde-allergy
- DermNet (Updated Jan 2024); Sulfonamides (sulfa drugs) and the skin. https://dermnetnz.org/topics/sulfa-drugs-and-the-skin
- Expert Review of Anticancer Therapy (Mar 2022); Vol. 22, Issue 3; Cemiplimab for locally advanced and metastatic basal cell carcinoma; pg. 243-248
- Fitzpatrick’s Dermatology, 9th ed. (2019); Ch. 105: Skin Changes and Diseases in Pregnancy. https://accessmedicine.mhmedical.com/content.aspx?bookid=2570&sectionid=210433140
- Gorlin Syndrome Alliance (Updated 2021); About Gorlin syndrome. https://gorlinsyndrome.org/about-gorlin-syndrome/
- Journal of Cutaneous Medicine and Surgery (Apr 2018); Vol. 22, Issue 5; Bullous pemphigoid: A 10-year study of discordant results on direct immunofluorescence; pg. 472-475
- Journal of Oral Pathology & Medicine (Feb 2008); Vol. 37, Issue 2; Herpes Simplex Virus Type 1 infection: Overview on relevant clinico-pathological features; pg. 107-121. https://pubmed.ncbi.nlm.nih.gov/18197856/
- Journal of the American Academy of Dermatology (Apr 2019); Vol. 80, Issue 4; Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics; pg. 1029-1072. https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext
- Journal of the American Academy of Dermatology (Nov 2022); Vol. 87, Issue 5; Systemic sclerosis in adults. Part I: Clinical features and pathogenesis; pg. 937-950
- Journal of the American Academy of Dermatology (Feb 2023); Vol. 88, Issue 2; Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders; pg. 271-288. https://pubmed.ncbi.nlm.nih.gov/35151757/
- Journal of the American Academy of Dermatology (Feb 2023); Vol. 88, Issue 2; Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders; pg. 271-288. https://pubmed.ncbi.nlm.nih.gov/35151757/
- Journal of the American Academy of Dermatology (Feb 2023); Vol. 88, Issue 2; Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation; pg. 291-320. https://pubmed.ncbi.nlm.nih.gov/35158001/
- Journal of the American Academy of Dermatology (Oct 2023); Vol. 89, Issue 4; Alpha-gal syndrome: A review for the dermatologist; pg. 750-757
- Journal of Wound Care (Jun 2016); Vol. 25, Issue 6; Recommendations for the management of biofilm: A consensus document; pg. 305-317
- Journal of Wound Care (Jun 2016); Vol. 25, Suppl 6; The management of patients with venous leg ulcers: Challenges and current best practice; pg. S1-S67
- Life-Threatening Rashes (Sep 2018); Erythroderma; pg. 265-277
- Local Flaps in Facial Reconstruction, 2nd ed. (2007); pg. 16
- Local Flaps in Facial Reconstruction, 2nd ed. (2007); pg. 80-92
- Local Flaps in Facial Reconstruction, 2nd ed. (2007); pg. 90-91
- MDHHS (Updated Jan 2018); Michigan’s five most common ticks. https://www.michigan.gov/-/media/Project/Websites/emergingdiseases/Folder2/5commonticks.pdf?rev=f3c6ffc6feda4e3a86f876b88298cc09
- Medscape (Updated Jun 2022); Diabetes devices may give kids contact dermatitis. https://www.medscape.com/viewarticle/976416#vp_1
- Missouri Medicine (Mar-Apr 2016); Vol. 113, Issue 2; A review of Raynaud’s disease; pg. 123-126
- Pancreas (Jul 2017); Vol. 46, Issue 6; The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors; pg. 707-714
- Plastic Surgery Key (Updated Mar 2016); Advancement flaps. https://plasticsurgerykey.com/advancement-flaps
- Plastic Surgery Key (Updated Dec 2016); Transposition flaps. https://plasticsurgerykey.com/transposition-flaps-2
- StatPearls (Updated Jul 2022); Interpolated flaps. https://pubmed.ncbi.nlm.nih.gov/29262248/
- StatPearls (Updated Feb 2024); Pemphigoid gestationis. https://www.ncbi.nlm.nih.gov/books/NBK470287/
- The American Journal of Dermatopathology (Jan 2021); Vol. 43, Issue 1; False-negative rate of direct immunofluorescence on lower extremities in bullous pemphigoid; pg. 42-44
- S. Food & Drug Administration (Updated Feb 2024); FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-lifileucel-unresectable-or-metastatic-melanoma
- VisualDx (Updated Mar 2020); Pemphigoid gestationis. https://www.visualdx.com/visualdx/diagnosis/?moduleId=101&diagnosisId=51692
- Weedon’s Skin Pathology, 5th ed. (2021); Ch. 27